Brief: Prelude Therapeutics Inc - On March 15, Co Entered Into An Open Market Sale Agreement With Jefferies Llc
15/03/2023 20:57
March 15 (Reuters) - Prelude Therapeutics Inc PRLD.O :
* PRELUDE THERAPEUTICS INC - ON MARCH 15, CO ENTERED INTO AN
OPEN
MARKET SALE AGREEMENT WITH JEFFERIES LLC
* PRELUDE THERAPEUTICS - DEAL TO SELL, SHARES OF COMMON
STOCK, OF
UP TO $75.0 MILLION
Source text: [ID:https://m5.gs/aVlKdV]
Further company coverage: PRLD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Prelude Therapeutics Incorporated
See all newsBrief: Prelude Announces Clinical Trial Collaboration And Supply Agreement With Lilly To Evaluate KAT6A Selective Degrader PRT13722 In Combination With Verzenio® And Inluriyo® In Patients With HR+/HER2- Breast Cancer
U.S. RESEARCH ROUNDUP-Celcuity, Fluence Energy, Salesforce
Prelude Therapeutics Incorporated reports results for the quarter ended June 30 - Earnings Summary
Prelude Therapeutics Q2 revenue beats analyst expectations, net loss narrows
Prelude Therapeutics Incorporated expected to post a loss of 20 cents a share - Earnings Preview